
A randomized trial comparing the ovulation induction efficacy of clomiphene citrate and letrozole
Author(s) -
Mary Angel,
Seetesh Ghose,
Mamata Gowda
Publication year - 2014
Publication title -
journal of natural science, biology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.236
H-Index - 30
eISSN - 2229-7707
pISSN - 0976-9668
DOI - 10.4103/0976-9668.136241
Subject(s) - letrozole , ovulation induction , anovulation , medicine , ovulation , follicular phase , infertility , aromatase inhibitor , randomized controlled trial , gynecology , pregnancy rate , clomifene , urology , andrology , pregnancy , aromatase , biology , polycystic ovary , insulin , hormone , insulin resistance , cancer , breast cancer , genetics
Letrazole is an aromatase inhibitor, which is useful in ovulation induction. However, evidence on its efficacy over clomiphene citrate, which is the first of drug used for therapy of anovulation, is insufficient in Indian patients.